Visit us at booth #813 and discover how you can empower your patients to be part of their wound treatment – literally.
Visit us at booth #813 and discover how you can empower your patients to be part of their wound treatment – literally.
The 3C Patch Wound Management System concentrates the body’s own living cells into a robust 3-layer patch to support wound healing.
Watch James McGuire, DPM, and Wound Center Director of the Temple University School of Podiatric Medicine, discussing the importance of autologous living cells in wound care.
3C Patch DINE & DEMO
Join us for dinner and an interactive 3C Patch workshop dedicated to healthcare specialists working on the front lines of chronic wound management.
Explore the innovative 3C Patch Wound Management System, the mode of action, and the clinical evidence. Learn about the practical aspects of implementing the 3C Patch Technology into the clinic workflow and the reimbursement process from fellow clinicians who are already using the 3C Patch in their wound care clinics.
3C Patch DINE & DEMO
Join us for dinner and an interactive 3C Patch workshop dedicated to healthcare specialists working on the front lines of chronic wound management.
Explore the innovative 3C Patch Wound Management System, the mode of action, and the clinical evidence. Learn about the practical aspects of implementing the 3C Patch Technology into the clinic workflow and the reimbursement process from fellow clinicians who are already using the 3C Patch in their wound care clinics.
Join us to learn about 3C Patch, a new personalized treatment option now available for chronic diabetic wounds.
1. 100% Autologous & Entirely alive
3C Patch represents a new category of advanced wound care modalities, different from current skin substitutes on the market. 3C Patch is a robust 3-layer leukocyte, platelet, and fibrin patch, created entirely from the patient’s own blood – nothing else. In-vitro studies have shown that the living cells in the 3C Patch can respond and adapt to the wound environment.
2. Clinically proven
3C Patch is backed by extensive clinical research, including a large (n=269), randomized, controlled trial published in The Lancet Diabetes & Endocrinology, 2018. The International Working Group of the Diabetic Foot recommends the use of 3C Patch – an autologous combined leukocyte, platelet, and fibrin patch as an adjunctive treatment in diabetic foot ulcers that are difficult to heal.
3. Implementation & Clinical Workflow
3C Patch is created through a fully automated centrifugation process that requires minimal hands-on time. We will dive into the practical aspects of implementing the 3C Patch in a busy clinic.
James B. McGuire, DPM, LPT, LPed
Wound Center Director of the Temple University School of Podiatric Medicine, Philadelphia, PA
Date: Saturday, July 30
Time: 6 PM – 7:30 PM EST
Location: Magnolia 13-14, Orlando World Center Marriott
RESERVE YOUR SEAT
This session is complimentary for registered APMA Annual Scientific Meeting 2022 attendees. The event is intended for healthcare professionals working to heal patients with chronic wounds. To register for this event, please fill in the form below – the seats are limited. You will receive a confirmation email after you submitted the form.
For questions, please contact cc@reapplix.com.
I want to attend the 3C Patch DINE & DEMO Event
CLINICIAN
“Autologous wound care products are probably the future in wound care. 3C Patch® is a hassle-free point-of-care, autologous treatment that you create using a simple automated procedure and place on the wound immediately.“ Read more…
Wound Center Director of the Temple University School of Podiatric Medicine
PATIENT
“I have been told that I was going to have my foot taken off and because I have a metal plate in my ankle it would have meant amputating at the knee. 3C Patch® is absolutely amazing.” Read more…
Philip Herbert
54-year-old patient, West Yorkshire
WOUND CARE SERVICE LINE DIRECTOR
Natchitoches Regional Medical Center, Louisiana
ONLY THE PATIENT’S LIVING CELLS TO SIGNIFICANTLY INCREASE THE CHANCES OF HEALING1
Clinically proven to heal more diabetic chronic wounds faster 1
3C Patch® is backed by extensive clinical research, including a large (n=269), randomized controlled trial published in The Lancet Diabetes & Endocrinology, 2018, showing that 58% more patients healed with 3C Patch® compared to standard of care, and the time for healing was significantly shorter (p=0.0246).
The 3C Patch® System is FDA cleared and nationally covered by Medicare.
3C Patch is recommended by IWGDF
The International Working Group on the Diabetic Foot (IWGDF) recommends the use of the 3C Patch® as an adjunctive treatment for non-infected diabetic foot ulcers that are difficult to heal.
TEAM APMA 5K CHALLENGE
Proceeds benefit the APMA Educational Foundation Student Scholarship Fund, which has given nearly $5 million in scholarships to podiatric medical students since 2005.
Sat July 30 – Tue August 2, 2022
Orlando, FL 32821 US
Reapplix is a Gold Sponsor for the Team APMA 5K Challenge – the race that supports the APMA Educational Foundation.
